HomeBCLI • OTCMKTS
add
Brainstorm Cell Therapeutics Inc
Previous close
$0.95
Day range
$0.83 - $0.94
Year range
$0.46 - $1.92
Market cap
9.52M USD
Avg Volume
23.21K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.24M | -29.63% |
Net income | -2.43M | 18.13% |
Net profit margin | — | — |
Earnings per share | -0.13 | 74.51% |
EBITDA | -2.20M | 29.97% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.00K | -84.49% |
Total assets | 1.02M | -44.21% |
Total liabilities | 11.01M | 14.70% |
Total equity | -9.98M | — |
Shares outstanding | 11.03M | — |
Price to book | -1.06 | — |
Return on assets | -467.11% | — |
Return on capital | 69.79% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.43M | 18.13% |
Cash from operations | -740.00K | 29.39% |
Cash from investing | — | — |
Cash from financing | 780.00K | -26.28% |
Net change in cash | 40.00K | 81.82% |
Free cash flow | -1.44M | -808.76% |
About
Founded
2000
Website
Employees
23
